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Abstract
Agricultural biotechnology continues to generate considerable controversy. We argue that
to address this controversy, serious changes to governance are needed. The new wave of
genomic tools and products (e.g., CRISPR, gene drives, RNAi, synthetic biology, and
genetically modified [GM] insects and fish), provide a particularly useful opportunity to
reflect on and revise agricultural biotechnology governance. In response, we present five
essential features to advance more socially responsible forms of governance. In presenting
these, we hope to stimulate further debate and action towards improved forms of gover-
nance, particularly as these new genomic tools and products continue to emerge.
This Perspective is part of the Public Engagement in Science Series.
An Opportunity to Reflect on Agricultural Biotechnology
Governance
Agricultural biotechnology continues to generate significant controversy. Much of this contro-
versy goes beyond questions about human and environmental safety to include concerns
regarding intellectual property and monopoly ownership rights, consolidating corporate con-
trol over seed markets and the food chain, consumers’ and farmers’ right to know and choose,
and challenges concerning the coexistence of different agricultural production systems. Exist-
ing regulatory frameworks struggle to address this wide range of concerns, as they largely rely
on scientific risk assessment of human and environmental health only.
The new wave of genomic tools and products place additional pressure on existing gover-
nance frameworks and provide a particularly useful opportunity to reflect on and revise agri-
cultural biotechnology governance. Some scientists argue that new genomic tools, such as gene
editing and the CRISPR/Cas9 method, will revolutionize biotechnology by allowing easy,
cheap, precise, and predictable genetic modification, while critics remain concerned about
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social and ethical implications and how existing regulatory frameworks will apply [1,2]. Along-
side the development of new tools, the next wave of agricultural biotechnology products
(beyond genetically modified [GM] crops) are now being approved for open field trials and
human consumption. For example, in 2014, the United States approved the first agricultural
GM insect, a GM diamondback moth, for open release. Applications have also been made for
releases of agricultural GM insects in Europe and Australia.
Given the entrenched controversy that has persisted around the use of GM crops, serious
reflection and changes to governance are needed for new biotechnology tools and products in
agricultural settings. Discussion about the regulatory status of the new suite of developments is
underway, highlighting the uncertainty that exists about whether these new genomic tools and
products fall outside existing definitions of GM organisms (GMOs) and regulatory require-
ments [3]. However, decisions about whether these products and techniques fall inside or out-
side existing regulatory frameworks are unlikely to address or appease the persistent
controversy.
In response to the limitations of current approaches to governance, calls have been made
for the full range of actors, including diverse public stakeholders, to carefully consider the risks
as well as the social and ethical concerns associated with the next wave of agricultural biotech-
nologies [2]. Alongside international responses to human genome editing [4], some examina-
tion of governance of these new genomics tools in agricultural biotechnology is also taking
place, with a focus on GM insects [5], gene drive research, and genome editing in nonhuman
organisms [6]. However, these efforts are narrowly focused on traditional regulatory oversight,
bioethics, and risk mitigation strategies and exclude the full range of potentially interested
actors.
Drawing on extensive scholarship on technology governance and the agricultural biotech-
nology controversy from across the fields of science and technology studies, responsible
research and innovation, and procedural ethics, we identify five common and essential features
that are interdependent rather than mutually exclusive and needed in order to advance more
socially responsible forms of governance. These are: commitment to candour, recognition of
underlying values and assumptions, involvement of a broad range of knowledge and actors,
consideration of a range of alternatives, and preparedness to respond. In presenting and elabo-
rating on these features below, we hope to stimulate further debate and action towards
improved forms of governance, particularly as new genomic tools and products continue to
emerge.
Five Essential Features of Responsible Governance of Agricultural
Biotechnology
1. Commitment to Candour
Responsible governance of agricultural biotechnologies first and foremost requires honesty and
humility about several factors embroiled in the controversy. These factors include: the scope
and quality of the available scientific knowledge, the underlying motivations for a technology’s
use and development, the realisability of claimed benefits, the range of concerns at stake (e.g.,
including those beyond physical risks), the information available in application dossiers, and
potential conflicts of interests in assessment and decision making.
The lack of candour in current risk regulatory frameworks is a foundation for public con-
cern [7,8]. Public stakeholders are not necessarily risk averse in the face of uncertainty. How-
ever, experience of past technological safety failures has sensitised people to the limits of
scientific knowledge and made them sceptical of those advocating complete knowledge and an
ability to predict and control technological risks in complex socioecological systems. A lack of
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truthfulness concerning the limits of scientific knowledge, motivations, expected benefits, and
the basis of conflict can lead to significant misunderstandings and mistrust between scientists,
policy makers, and the public. Certainty and predictability are typically considered to be a mea-
surement of competence [9]; however, candidly recognising and truthfully representing scien-
tific uncertainties and the full range of concerns at stake does not reflect a lack of competence.
Rather, such candour allows debate to move beyond the unhelpful illusion of technological
control and open up for a broader and more inclusive discussion about the role of technology
in addressing socioecological challenges [7].
Social science research has suggested several ways to encourage honesty and humility in the
governance practices of agricultural biotechnologies. For example, work by Andy Stirling has
usefully articulated different types of scientific uncertainty and identified available methods for
understanding, identifying, and addressing them [10]. Furthermore, some of the factors mak-
ing biotechnology particularly prone to inflated hype have been highlighted (e.g., pressures to
publish, the increasing commercialisation agenda, and media representations), and concrete
changes to address these have also been identified (such as altered incentive structures, inde-
pendent resources, enhanced scepticism, and a robust and critical role for media) [11].
2. Recognition of Underlying Values and Assumptions
Responsible governance also requires that actors reflect upon how values and assumptions
shape both science and innovation and risk assessment and management. Recognising under-
lying values and assumptions in innovation and governance systems can make explicit the
diverse ways there are to approach how desirable futures are imagined, how problems and solu-
tions are framed and understood, and how risk-based science and assessment are performed.
Risk assessment, as the foundation of existing governance frameworks for agricultural bio-
technology, is regularly claimed to be “science-based” and free of values. Without recognition,
the values-based choices made by risk assessors and the scientific experts advising them are
hidden from public scrutiny but continue to generate controversy [8,12]. Recognising the sig-
nificance of values-choices and the underlying assumptions of different actors would reveal
divergent views and allow them to be negotiated and addressed directly rather than hiding
them within a narrow debate about human and environmental risk. This would in turn enable
more transparent decision making and effective dialogue between innovators, risk assessors,
risk managers, policy makers, and publics.
One approach advocated by social scientists to help facilitate the recognition of underlying
values and assumptions is to create meeting places where actors with different knowledge and
ideas are invited to contribute to shaping agricultural biotechnology decisions in both scientific
research and risk regulation. This is important because it is often in meetings between people
of different views, backgrounds, and understandings that underlying values and assumptions
are revealed. One illustrative example is the approach taken in Socio-Technical Integration
Research, in which scholars from the social sciences and humanities are embedded into labora-
tories to help scientists reflect upon their research decisions, recognise their value choices,
explore alternatives, and integrate broader social and ethical considerations into their routine
activities [13].
3. Involvement of a Broad Range of Knowledges and Actors
A commitment to candour and acknowledgement of values and assumptions facilitates deci-
sion making to be opened up to a plurality of perspectives, views, and diverse types of knowl-
edge from a broad range of actors, including both different scientific disciplines (e.g.,
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molecular biology and ecology) and different stakeholders (e.g., farmers, citizens, and civil soci-
ety organisations).
When the debate about agricultural biotechnology is confined to a technical assessment of
risks to human and environmental health, it limits who can legitimately participate in deci-
sion-making processes, privileging technical experts [12,14]. The inclusion of nontechnical
experts is currently confined to the end of the risk assessment process, when public stakehold-
ers are invited to comment on expert-defined assessments of environmental and human health
risk without much potential for influence [12]. However, as we have argued, the debate about
agricultural biotechnology is not only a technical debate about physical risks: it involves other
ethical and social concerns [14]. Opening up innovation governance to a broader range of
knowledge sources and perspectives allows social and ethical concerns to be directly incorpo-
rated and addressed in decision making. However, it also has normative value by making the
process more democratically legitimate and can substantively improve decision making by cre-
ating a more comprehensive knowledge base [15,16].
The importance of engaging the public in the governance of agricultural biotechnology has
received increased attention and experimentation over the years, not only from social scientists
but also from policy makers and nongovernmental organisations. This has led to work with
diverse methods such as citizen juries, consensus conferences, science cafes, and public dia-
logues and meetings. While many of these attempts at public engagement have received signifi-
cant criticism for their narrow framing, selection of participants, limited impact, and/or their
search for legitimation rather than genuine debate [7,12,17], there is arguably a learning pro-
cess in motion. For example, calls have been made to move engagement efforts further
“upstream” in the innovation process to ensure that these discussions do not occur too late
(e.g., when trajectories have been set, precious research funds invested, and decisions effectively
made) [18]. Examples such as the Rothamsted Research institute meeting with stakeholders
before running experimental GM wheat field trials arguably represents a small step in the right
direction [19].
4. Consideration of a Range of Alternatives
Responsible governance of agricultural biotechnology should not just candidly and inclusively
consider the risks and societal and ethical concerns associated with a particular technology but
should also consider the range of alternative ways to formulate and frame the problems at stake
as well as the range of alternative approaches to solving them.
Agricultural systems are under severe stress from converging problems associated with soil
deterioration, water scarcity, chemical pollution, climate change, and population growth. At
present, policies to address these problems typically focus on the problems in isolation and call
almost exclusively on science and technology narrowly defined for solutions [20]. Assessing
individual technologies in isolation for only their potential risks encourages a narrow focus on
issues of risk governance rather than a broader interest in innovation governance or “problem
governance” and does not support the development of “wicked solutions” [21] capable of
addressing multiple concerns simultaneously.
Social scientists again have relevant work to offer in the practical implementation of this fea-
ture, such as the development of methods designed to facilitate the consideration of a range of
technological alternatives and policy options. One promising method here is Multicriteria
Mapping, which uses web-based software to help scientists, risk assessors, or others to explore
different options available for addressing a defined problem on the basis of a range of flexible
evaluative criteria [22]. This technique not only enables a clear picture to be developed about
how different stakeholders view the available alternatives and how they weight different
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evaluative criteria, it also captures how they see the uncertainties involved and how these
uncertainties affect their preferences and decision making. This allows biotechnologies to be
compared with a range of other technologies for their potential to address the problem at hand
against diverse evaluative criteria [23].
5. Preparedness to Respond
For all of the above features to function effectively, innovators, risk researchers, regulators, and
policy makers need to be willing and prepared to consider and respond to societal needs and
concerns as well as to new scientific knowledge, changing values, diverse interpretations of
potential consequences, and shifting socioecological conditions.
This preparedness to respond to matters of societal concern and changing conditions is
important not only for ensuring the democratic accountability of science and technology in lib-
eral democracies but also as a means to enhance reversibility, adaptability, and resilience in
innovation and policy systems in the face of change [16]. The inherent limitations of scientific
knowledge and our inability to fully predict and control agricultural biotechnologies in
dynamic natural systems places further emphasis on the need for preparedness and a willing-
ness to respond.
Responding to societal concerns and changing socioecological conditions requires moving
beyond dichotomous stop-go decisions towards more nuanced considerations of how, when,
under what conditions, and in what directions, we may wish to move forward. For example, in
a recent case in the US, societal concerns prompted researchers at Cornell University to reex-
amine the timetable for releasing the GM diamondback moth in open field trials. Despite
receiving a regulatory permit for open releases, researchers delayed open field trials, framing
the decision as “responsible science” [24]. This means that the response to societal concern was
not simply about moving forward with the technology in the face of concern or stopping it
entirely but also about considering questions regarding the appropriate speed of development
and what further research may be required and conducted so as to address the concerns raised.
Conclusion
Agricultural biotechnology, like all innovation, is a future-oriented endeavour, and therefore
its governance necessarily requires balancing the desire to harness potential future benefits
with sensitivity to existing uncertainties and a constructive engagement with diverse societal
needs and concerns. The five essential features of responsible governance that we provide here
are intended to help stimulate a broader discussion about how to imagine and enact this bal-
ancing through developing scientifically and socially responsible governance of agricultural
biotechnologies. Such discussion is particularly salient as new genomic tools and products
emerge into a milieu where the controversies that embroil GM crops remain unresolved.
Adopting these essential features of agricultural biotechnology governance is no small task. We
have provided some illustrative examples from social science research of attempts to move gov-
ernance practices of agricultural biotechnologies in this direction. While we recognise that
each of these practical examples have their limitations and possible critiques, we nevertheless
see them as small steps towards the type of deep cultural change that is needed to fully enact
the features we advocate. Although these essential features are not intended to be comprehen-
sive or definitive, they are interconnected, and we would argue that they need to be consistently
cultivated, encouraged, and reinforced, in both individuals and institutions over time, until
innovation and governance systems gradually evolve into more responsible forms that success-
fully serve a broader range of socioecological goals.
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